Registration Frequencies

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 972 25
Brodalumab 152 0
Certolizumab 31 0
Efalizumab 35 0
Etanercept 346 42
Golimumab 26 0
Guselkumab 251 0
Infliximab 99 1
Ixekizumab 235 0
Secukinumab 974 0
Tildrakizumab 34 0
Ustekinumab 647 0
Apremilast 371 0
Ciclosporin 360 0
Fumaderm 2524 0
Skilarence 804 0
Methotrexate 2482 0
other systemics 327 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers